FDA rejects psychedelic MDMA as treatment for PTSD
WASHINGTON — The U.S. Food and Drug Administration on Friday rejected approval of the psychedelic drug MDMA to treat PTSD, a major setback for groups seeking a landmark ruling in…
WASHINGTON — The U.S. Food and Drug Administration on Friday rejected approval of the psychedelic drug MDMA to treat PTSD, a major setback for groups seeking a landmark ruling in…
